ZFP2
gene geneOn this page
Also known as FLJ21628ZNF751
Summary
ZFP2 (ZFP2 zinc finger protein, HGNC:26138) is a protein-coding gene on chromosome 5q35.3, encoding Zinc finger protein ZFP2 (Q6ZN57). Probable transcription factor involved in neuronal differentiation and/or phenotypic maintenance.
Predicted to enable DNA-binding transcription factor activity, RNA polymerase II-specific and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.
Source: NCBI Gene 80108 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 82 total
- MANE Select transcript:
NM_030613
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:26138 |
| Approved symbol | ZFP2 |
| Name | ZFP2 zinc finger protein |
| Location | 5q35.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ21628, ZNF751 |
| Ensembl gene | ENSG00000198939 |
| Ensembl biotype | protein_coding |
| Entrez | 80108 |
Gene structure
Transcript identifiers
Ensembl transcripts: 26 — 26 protein_coding
ENST00000361362, ENST00000520301, ENST00000520660, ENST00000520805, ENST00000523286, ENST00000896567, ENST00000896568, ENST00000896569, ENST00000896570, ENST00000896571, ENST00000896572, ENST00000896573, ENST00000896574, ENST00000896575, ENST00000896576, ENST00000896577, ENST00000896578, ENST00000916756, ENST00000916757, ENST00000916758, ENST00000916759, ENST00000916760, ENST00000916761, ENST00000960763, ENST00000960764, ENST00000960765
RefSeq mRNA: 1 — MANE Select: NM_030613
NM_030613
CCDS: CCDS4440
Canonical transcript exons
ENST00000361362 — 5 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001419935 | 178931237 | 178933212 |
| ENSE00001425671 | 178916565 | 178916710 |
| ENSE00001430074 | 178912584 | 178912719 |
| ENSE00001432484 | 178912982 | 178913071 |
| ENSE00002134632 | 178895913 | 178895974 |
Expression profiles
Bgee: expression breadth ubiquitous, 173 present calls, max score 88.85.
FANTOM5 (CAGE): breadth broad, TPM avg 1.2642 / max 57.4145, expressed in 556 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 60533 | 1.2642 | 556 |
Top tissues by expression
270 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 88.85 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.44 | gold quality |
| cortical plate | UBERON:0005343 | 77.51 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 76.10 | gold quality |
| cerebellar cortex | UBERON:0002129 | 76.03 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 75.46 | gold quality |
| cerebellum | UBERON:0002037 | 74.40 | gold quality |
| ventricular zone | UBERON:0003053 | 74.36 | gold quality |
| mucosa of stomach | UBERON:0001199 | 73.70 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 72.83 | gold quality |
| ganglionic eminence | UBERON:0004023 | 72.82 | gold quality |
| lower esophagus | UBERON:0013473 | 72.78 | gold quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 72.58 | gold quality |
| body of uterus | UBERON:0009853 | 72.56 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 72.55 | gold quality |
| right frontal lobe | UBERON:0002810 | 72.05 | gold quality |
| tibial artery | UBERON:0007610 | 71.46 | gold quality |
| popliteal artery | UBERON:0002250 | 71.45 | gold quality |
| right coronary artery | UBERON:0001625 | 71.19 | gold quality |
| right uterine tube | UBERON:0001302 | 71.16 | gold quality |
| right ovary | UBERON:0002118 | 71.08 | gold quality |
| pigmented layer of retina | UBERON:0001782 | 71.01 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 70.95 | gold quality |
| cingulate cortex | UBERON:0003027 | 70.86 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 70.83 | gold quality |
| left ovary | UBERON:0002119 | 70.58 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 70.46 | gold quality |
| left uterine tube | UBERON:0001303 | 70.34 | gold quality |
| prefrontal cortex | UBERON:0000451 | 70.26 | gold quality |
| endocervix | UBERON:0000458 | 70.07 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 4.63 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
34 targeting ZFP2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-188-3P | 100.00 | 68.76 | 1240 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-5696 | 99.98 | 72.36 | 4487 |
| HSA-MIR-651-3P | 99.94 | 73.48 | 5177 |
| HSA-MIR-3133 | 99.81 | 70.92 | 3506 |
| HSA-MIR-4320 | 99.75 | 65.80 | 793 |
| HSA-MIR-4428 | 99.73 | 66.41 | 1733 |
| HSA-MIR-1179 | 99.71 | 68.70 | 1040 |
| HSA-MIR-4729 | 99.69 | 72.18 | 4233 |
| HSA-MIR-199A-5P | 99.51 | 69.71 | 1107 |
| HSA-MIR-199B-5P | 99.51 | 69.74 | 1098 |
| HSA-MIR-12132 | 99.47 | 68.90 | 1341 |
| HSA-MIR-519D-5P | 99.41 | 69.30 | 2057 |
| HSA-MIR-3191-5P | 99.24 | 66.52 | 1722 |
| HSA-MIR-593-3P | 99.22 | 67.28 | 1327 |
| HSA-MIR-664A-3P | 99.22 | 71.08 | 2696 |
| HSA-MIR-4528 | 99.18 | 69.77 | 1936 |
| HSA-MIR-4424 | 98.91 | 70.33 | 1145 |
| HSA-MIR-382-3P | 98.83 | 67.10 | 1074 |
| HSA-MIR-7977 | 98.65 | 66.18 | 2590 |
| HSA-MIR-12125 | 98.59 | 67.54 | 1044 |
| HSA-MIR-3145-5P | 98.57 | 67.83 | 900 |
| HSA-MIR-1237-3P | 98.55 | 67.65 | 1423 |
| HSA-MIR-4684-5P | 98.29 | 67.99 | 1650 |
| HSA-MIR-490-3P | 97.79 | 65.54 | 606 |
| HSA-MIR-4456 | 97.50 | 64.88 | 1678 |
| HSA-MIR-4640-5P | 97.42 | 66.33 | 1543 |
| HSA-MIR-5187-3P | 97.28 | 67.10 | 1037 |
| HSA-MIR-4726-5P | 97.24 | 65.67 | 1299 |
Cross-species orthologs
2 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Zfp2 | ENSMUSG00000049321 |
| rattus_norvegicus | Zfp2 | ENSRNOG00000030750 |
Paralogs (176): ZNF195 (ENSG00000005801), ZNF112 (ENSG00000062370), ZNF275 (ENSG00000063587), ZNF37A (ENSG00000075407), ZNF510 (ENSG00000081386), ZNF506 (ENSG00000081665), ZNF268 (ENSG00000090612), MZF1 (ENSG00000099326), ZNF629 (ENSG00000102870), ZNF175 (ENSG00000105497), ZNF85 (ENSG00000105750), ZFP30 (ENSG00000120784), ZNF45 (ENSG00000124459), ZNF391 (ENSG00000124613), ZNF436 (ENSG00000125945), ZNF484 (ENSG00000127081), ZNF835 (ENSG00000127903), ZNF780B (ENSG00000128000), ZSCAN10 (ENSG00000130182), ZNF317 (ENSG00000130803), ZNF331 (ENSG00000130844), ZNF227 (ENSG00000131115), ZNF141 (ENSG00000131127), ZNF132 (ENSG00000131849), ZNF189 (ENSG00000136870), ZIM3 (ENSG00000141946), ZFP14 (ENSG00000142065), ZNF514 (ENSG00000144026), ZNF300 (ENSG00000145908), RBAK (ENSG00000146587), ZNF157 (ENSG00000147117), ZNF182 (ENSG00000147118), ZNF41 (ENSG00000147124), ZNF7 (ENSG00000147789), ZNF117 (ENSG00000152926), ZNF221 (ENSG00000159905), ZNF235 (ENSG00000159917), ZNF714 (ENSG00000160352), ZNF577 (ENSG00000161551), ZNF12 (ENSG00000164631)
Protein
Protein identifiers
Zinc finger protein ZFP2 — Q6ZN57 (reviewed: Q6ZN57)
Alternative names: Zinc finger protein 751
All UniProt accessions (3): Q6ZN57, A0A1D5RMT2, E5RJD3
UniProt curated annotations — full annotation on UniProt →
Function. Probable transcription factor involved in neuronal differentiation and/or phenotypic maintenance.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
RefSeq proteins (1): NP_085116* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
Pfam: PF00096
UniProt features (16 total): zinc finger region 13, sequence variant 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q6ZN57-F1 | 79.80 | 0.73 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 76 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_COLON_TUMORAL_MACROPHAGE_DN, AACTGGA_MIR145, TGGAAA_NFAT_Q4_01, XU_GH1_EXOGENOUS_TARGETS_DN, SANSOM_APC_MYC_TARGETS, SANSOM_APC_TARGETS_REQUIRE_MYC, STAT1_02, YKACATTT_UNKNOWN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP, STAT1_03, TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_DN, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY
GO Biological Process (2): regulation of transcription by RNA polymerase II (GO:0006357), negative regulation of DNA-templated transcription (GO:0045892)
GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity, RNA polymerase II-specific (GO:0000981), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of DNA-templated transcription | 2 |
| RNA polymerase II transcription regulatory region sequence-specific DNA binding | 2 |
| transcription by RNA polymerase II | 1 |
| DNA-templated transcription | 1 |
| negative regulation of RNA biosynthetic process | 1 |
| cis-regulatory region sequence-specific DNA binding | 1 |
| chromatin | 1 |
| DNA-binding transcription factor activity | 1 |
| regulation of transcription by RNA polymerase II | 1 |
| transition metal ion binding | 1 |
| nucleic acid binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
414 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZFP2 | RBM27 | Q9P2N5 | 380 |
| ZFP2 | ZC3H11D | Q8NA57 | 370 |
| ZFP2 | BIVM | Q86UB2 | 336 |
| ZFP2 | POLR2L | P52436 | 335 |
| ZFP2 | TP53 | P04637 | 332 |
| ZFP2 | TIGD7 | Q6NT04 | 327 |
| ZFP2 | NBPF14 | Q5TI25 | 290 |
| ZFP2 | TTPAL | Q9BTX7 | 289 |
| ZFP2 | TSPYL5 | Q86VY4 | 288 |
| ZFP2 | ZMAT5 | Q9UDW3 | 287 |
| ZFP2 | KLHDC1 | Q8N7A1 | 287 |
| ZFP2 | TMEM144 | Q7Z5S9 | 285 |
| ZFP2 | TCEAL2 | Q9H3H9 | 275 |
| ZFP2 | LIX1L | Q8IVB5 | 272 |
| ZFP2 | A0A0A6YYG8 | A0A0A6YYG8 | 269 |
IntAct
71 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| MAP3K20 | ZFP2 | psi-mi:“MI:0915”(physical association) | 0.780 |
| ZFP2 | MAP3K20 | psi-mi:“MI:0915”(physical association) | 0.780 |
| KRT40 | ZFP2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZFP2 | TRIM41 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZFP2 | KRT40 | psi-mi:“MI:0915”(physical association) | 0.720 |
| TRIM41 | ZFP2 | psi-mi:“MI:0915”(physical association) | 0.720 |
| ZFP2 | GOLGA2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP2 | MTUS2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BCDIN3D | ZFP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| GOLGA2 | ZFP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MTUS2 | ZFP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP2 | BCDIN3D | psi-mi:“MI:0915”(physical association) | 0.560 |
| IPO8 | ZFP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP2 | PICK1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP2 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| ZFP2 | DMWD | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP2 | psi-mi:“MI:0915”(physical association) | 0.560 | |
| LMNA | ZFP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TSC1 | ZFP2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZFP2 | SPRED1 | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (19): ZFP2 (Two-hybrid), ZFP2 (Two-hybrid), ZFP2 (Two-hybrid), TRIM41 (Two-hybrid), KRT40 (Two-hybrid), BCDIN3D (Two-hybrid), ZFP2 (Two-hybrid), ZFP2 (Affinity Capture-MS), ZFP2 (Affinity Capture-MS), ZFP2 (Two-hybrid), ZFP2 (Two-hybrid), ZFP2 (Two-hybrid), ZFP2 (Two-hybrid), ZFP2 (Two-hybrid), KRT40 (Two-hybrid)
ESM2 similar proteins: A2VDQ7, A6NNF4, A8MQ14, A8MTY0, E9QAG8, O75290, O75373, P08043, P0CJ79, P10751, P17017, P17027, P17039, P35789, P51522, P51523, Q08AN1, Q14585, Q14587, Q3SYV7, Q3ZCX4, Q4R4C7, Q52M93, Q5MCW4, Q5R5U3, Q5R8X1, Q5R9F0, Q5SXM1, Q6ECI4, Q6JLC9, Q6P3V2, Q6P5C7, Q6ZN57, Q86UE3, Q86XN6, Q86YE8, Q8C827, Q8IYB9, Q8N4W9, Q8N7M2
Diamond homologs: P08043, Q6ZN57, Q8N859, Q96ND8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
82 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 77 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1313 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 5:178895971:GAGG:G | donor_gain | 1.0000 |
| 5:178895973:GG:G | donor_gain | 1.0000 |
| 5:178895974:GG:G | donor_gain | 1.0000 |
| 5:178913070:AGG:A | donor_loss | 1.0000 |
| 5:178913072:GT:G | donor_loss | 1.0000 |
| 5:178913073:T:A | donor_loss | 1.0000 |
| 5:178895975:G:GG | donor_gain | 0.9900 |
| 5:178895976:TGAG:T | donor_loss | 0.9900 |
| 5:178895977:GAGT:G | donor_loss | 0.9900 |
| 5:178898577:A:AG | acceptor_gain | 0.9900 |
| 5:178898578:G:GG | acceptor_gain | 0.9900 |
| 5:178898578:GCTCT:G | acceptor_gain | 0.9900 |
| 5:178899858:G:GG | donor_gain | 0.9900 |
| 5:178912977:A:G | acceptor_gain | 0.9900 |
| 5:178913069:GAG:G | donor_gain | 0.9800 |
| 5:178913072:G:GG | donor_gain | 0.9800 |
| 5:178931236:GACT:G | acceptor_gain | 0.9800 |
| 5:178898575:TCAG:T | acceptor_loss | 0.9700 |
| 5:178898576:CA:C | acceptor_loss | 0.9700 |
| 5:178898577:A:AT | acceptor_loss | 0.9700 |
| 5:178898578:GCTC:G | acceptor_gain | 0.9700 |
| 5:178912718:GG:G | donor_gain | 0.9700 |
| 5:178912719:GG:G | donor_gain | 0.9700 |
| 5:178931235:A:AG | acceptor_gain | 0.9700 |
| 5:178931235:AGACT:A | acceptor_gain | 0.9700 |
| 5:178931236:G:GG | acceptor_gain | 0.9700 |
| 5:178931236:GACTG:G | acceptor_gain | 0.9700 |
| 5:178898578:GCT:G | acceptor_gain | 0.9600 |
| 5:178912978:G:GG | acceptor_gain | 0.9600 |
| 5:178912979:CAG:C | acceptor_loss | 0.9600 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000199107 (5:178896028 C>A), RS1000229326 (5:178932212 G>A,T), RS1000232035 (5:178899642 C>T), RS1000334680 (5:178933035 G>A), RS1000382886 (5:178920310 A>G), RS1000390432 (5:178926678 G>A), RS1000551197 (5:178919053 C>T), RS1000619468 (5:178902022 C>G), RS1000715517 (5:178921633 A>G), RS1000800793 (5:178928201 C>T), RS1000851676 (5:178921882 G>A), RS1000878393 (5:178919951 G>A), RS1000894109 (5:178927892 C>G,T), RS1000912958 (5:178908055 C>T), RS1001138406 (5:178906187 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST010002_45 | Refractive error | 9.000000e-17 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | affects cotreatment, decreases expression | 5 |
| trichostatin A | affects cotreatment, decreases expression | 3 |
| entinostat | decreases expression, affects cotreatment | 2 |
| Nickel | decreases expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| propionaldehyde | increases expression | 1 |
| bisphenol A | increases expression | 1 |
| tri-o-cresyl phosphate | increases expression | 1 |
| hydroquinone | decreases expression | 1 |
| 15-acetyldeoxynivalenol | increases expression | 1 |
| 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | affects cotreatment, decreases expression | 1 |
| dorsomorphin | affects cotreatment, decreases expression | 1 |
| Panobinostat | decreases expression, affects cotreatment | 1 |
| Benzo(a)pyrene | affects methylation, decreases methylation | 1 |
| Methotrexate | increases expression | 1 |
| Phenylmercuric Acetate | affects cotreatment, decreases expression | 1 |
| Silicon Dioxide | increases expression | 1 |
| Smoke | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Cellosaurus cell lines
1 cell lines: 1 transformed cell line
First 10 cell lines (id-ordered, not curated):
| Cellosaurus | Name | Category | Sex |
|---|---|---|---|
| CVCL_XV95 | HEK293 eGFP-ZFP2 | Transformed cell line | Female |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.